Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China · Delayed Price · Currency is CNY

24.27

+0.86 (3.67%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Biopharmaceutical Segment	194.92M	190.14M	174.22M	208.69M	185.56M
Biopharmaceutical Segment Growth	2.51%	9.14%	-16.52%	12.47%	-1.35%
Total	194.92M	190.14M	174.22M	208.69M	185.56M
Total Growth	2.51%	9.14%	-16.52%	12.47%	-1.35%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
China	193.50M	-	-	-	184.20M
China Growth	-	-	-	-	-1.44%
Overseas	1.41M	-	-	-	1.36M
Overseas Growth	-	-	-	-	47.36%
Total	194.92M	-	-	-	185.56M
Total Growth	-	-	-	-	-1.20%

Source: S&P Global Market Intelligence.